Sort
39,280 grants matching “leukemia”
Structural and Biochemical Studies of Jak2
$423,750Stevan R. Hubbard · New York University School Of Medicine · R01 · FY2019 · AI
Mechanisms of DNA interstrand cross-link repair
$423,750Johannes Walter · Harvard Medical School · R01 · FY2016 · HL
The Fanconi anemia pathway: role in DNA interstrand cross-link repair
$423,750Johannes Walter · Harvard Medical School · R01 · FY2010 · HL
Modeling chromosome 7 loss in Myelodysplasia-iPSCs
$423,750Eirini Papapetrou · Icahn School Of Medicine At Mount Sinai · R01 · FY2017 · HL
Mechanisms of DNA interstrand cross-link repair
$423,750Johannes Walter · Harvard Medical School · R01 · FY2023 · HL
Genetic regulation of hematopoietic stem cells
$423,750Hans-Willem E Snoeck · Icahn School Of Medicine At Mount Sinai · R01 · FY2010 · HL
Genetic regulation of hematopoietic stem cells
$423,750Hans-Willem E Snoeck · Icahn School Of Medicine At Mount Sinai · R01 · FY2011 · HL
Mechanisms of DNA interstrand cross-link repair
$423,750Johannes Walter · Harvard Medical School · R01 · FY2020 · HL
Mechanisms of DNA interstrand cross-link repair
$423,750Johannes Walter · Harvard Medical School · R01 · FY2017 · HL
Structural and Biochemical Studies of Jak2
$423,750Stevan R. Hubbard · New York University School Of Medicine · R01 · FY2016 · AI
Mechanisms of DNA interstrand cross-link repair
$423,750Johannes Walter · Harvard Medical School · R01 · FY2021 · HL
Genetic Etiology of Agammaglobulinemia with Absent B Cells
$423,750Mary Ellen Conley · Rockefeller University · R01 · FY2014 · AI
Structure and Functions of Steroid Hormone Receptors
$423,732H Eric Xu · Van Andel Research Institute · R01 · FY2010 · DK
Mechanisms mediating resistance to ibrutinib in Non-Hodgkin's lymphoma
$423,680Richard Goff James · Seattle Children'S Hospital · R01 · FY2021 · CA
Personalized Risk-AdaptIve Surveillance (PRAISE) - Implications of Algorithmic Bias
$423,669Aasthaa Bansal · University Of Washington · R37 · FY2024 · CA
Mechanisms mediating resistance to ibrutinib in Non-Hodgkin's lymphoma
$423,667Richard Goff James · Seattle Children'S Hospital · R01 · FY2020 · CA
Directing the metabolic fate of CAR T cells
$423,662Carl H. June · University Of Pennsylvania · R01 · FY2022 · CA
Epigenetic drivers of cancer progression
$423,649Andrew P Feinberg · Johns Hopkins University · R01 · FY2022 · CA
Mechanisms of Hematopoietic Stem Cell Transformation
$423,604Emmanuelle Passegue · University Of California, San Francisco · R01 · FY2016 · HL
Enhancing Treg Therapeutic Efficacy in GVHD
$423,548Bruce R. Blazar · University Of Minnesota · R01 · FY2015 · HL
DNMT3A MUTATIONS IN ACUTE MYELOID LEUKEMIA
$423,527Timothy J Ley · Washington University · R01 · FY2014 · CA
Targeting the Bone Marrow Microenvironment In Acute Lymphocytic Leukemia
$423,502Geoffrey L Uy · Washington University · P50 · FY2017 · CA
ELUCIDATION & MODULATION OF NATURAL KILLER CELL SIGNALING: APPLICATION IN CANCER
$423,497Michael A Caligiuri · Ohio State University · P01 · FY2010 · CA
Gamma Globin Gene Therapy Using In Vivo Selection
$423,476Derek A Persons · St. Jude Children'S Research Hospital · U54 · FY2007 · HL
The role of H3K79 methylation in IDH-mutant leukemia
$423,410Kathrin M Bernt · Children'S Hosp Of Philadelphia · R01 · FY2019 · CA